Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Diagnostic and prognostic value of a 7-panel mutation testing in thyroid nodules with indeterminate cytology: the SWEETMAC study.

Endocrine - 1 Feb 2021

Bardet Stéphane, Goardon Nicolas, Lequesne Justine, Vaur Dominique, Ciappuccini Renaud, Leconte Alexandra, Monpeyssen Hervé, Saguet-Rysanek Virginie, Clarisse Bénédicte, Lasne-Cardon Audrey, Ménégaux Fabrice, Leenhardt Laurence, Buffet Camille

Abstract excerpt

PURPOSE: The aim of this prospective study (ClinicalTrials.gov: NCT01880203) was to evaluate the diagnostic and prognostic value of a 7-panel mutation testing in the aspirates of thyroid nodules with indeterminate cytology (IC). METHODS: Eligible patients had a thyroid nodule ≥15 mm with IC (Bethesda III-V) for which surgery had been recommended. Detection of BRAF and RAS mutations was performed using...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biopsy, Fine-Needle
Share to Carcinoma, Hepatocellular

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to DNA Mutational Analysis

Share to Liver Neoplasms

Share to Prognosis

Share to Proto-Oncogene Proteins B-raf

Share to Thyroid Neoplasms

Share to Thyroid Nodule

Source

Open in PubMed Open full text

Identifiers

PMID: 32638211
DOI: 10.1007/s12020-020-02411-4
PMCID: PMC7881964

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Diagnostic and prognostic value of a 7-panel mutation testing in thyroid nodules with indeterminate cytology: the SWEETMAC study.PMID 32638211Read ↗

Clinical utility of a microRNA classifier in cytologically indeterminate thyroid nodules with RAS mutations: A multi-institutional study.Semantic proximity Read ↗

Testing of mutations on thyroid nodules with indeterminate cytology: A prospective study of 112 patients in Argentina.Semantic proximity Read ↗

Performance of Seven-Gene Panel Testing for Risk Stratification of Thyroid Nodules with Indeterminate Cytology Results.Semantic proximity Read ↗

How genetics changed or will change the therapy in thyroid nodules with indeterminate cytology?Semantic proximity Read ↗

The actual and future role of molecular tests in thyroid pathology.Semantic proximity Read ↗

Update on Molecular Diagnostics in Thyroid Pathology: A ReviewSemantic proximity Read ↗

Molecular Profiling for Bethesda III to VI Nodules: Results of a Multicenter International Retrospective Study.Semantic proximity Read ↗

Preoperative molecular testing in thyroid nodules with Bethesda VI cytology: Clinical experience and review of the literature.Semantic proximity Read ↗

Current State of Molecular Cytology in Thyroid Nodules: Platforms and their Diagnostic and Theranostic UtilitySemantic proximity Read ↗

New strategies in diagnosing cancer in thyroid nodules: impact of molecular markers.Semantic proximity Read ↗

Real-life utility of five-gene panel test in preoperative thyroid fine-needle aspiration biopsy: a large cohort of 740 patients study.Semantic proximity Read ↗

Clinical performance of multiplatform mutation panel and microRNA risk classifier in indeterminate thyroid nodules.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.